Samil Pharm (000520) — Cash Flow-to-Debt Ratio
Latest as of June 2025:
0.01x
Samil Pharm (000520) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of ₩2.44 Billion could theoretically repay 0% of its total liabilities (₩226.31 Billion) in one year. Explore investment intensity of Samil Pharm to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
0.01x
Operating CF / Total Liabilities
Operating Cash Flow
₩2.44 Billion
KRW
Total Liabilities
₩226.31 Billion
KRW
Data as of
Jun 2025
Most recent filing
Samil Pharm Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Samil Pharm across 13 annual periods. Also explore total assets of Samil Pharm for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Samil Pharm (2012–2024)
Year-by-year debt coverage analysis for Samil Pharm. For market capitalisation and broader financial context, see how much is Samil Pharm worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | ₩2.59 Billion | ₩218.95 Billion | ▼ -75.5% |
| 2023 | 0.05x | ₩11.75 Billion | ₩242.85 Billion | ▲ +168.8% |
| 2022 | 0.02x | ₩4.15 Billion | ₩230.88 Billion | ▲ +104.0% |
| 2021 | 0.01x | ₩1.42 Billion | ₩160.66 Billion | ▼ -85.5% |
| 2020 | 0.06x | ₩7.77 Billion | ₩128.11 Billion | ▼ -30.3% |
| 2019 | 0.09x | ₩10.59 Billion | ₩121.60 Billion | ▲ +405.2% |
| 2018 | -0.03x | ₩-2.62 Billion | ₩91.87 Billion | ▼ -163.5% |
| 2017 | 0.04x | ₩3.79 Billion | ₩84.31 Billion | ▼ -61.6% |
| 2016 | 0.12x | ₩5.63 Billion | ₩48.12 Billion | ▲ +80.0% |
| 2015 | 0.07x | ₩2.92 Billion | ₩44.90 Billion | ▲ +128.8% |
| 2014 | -0.23x | ₩-11.92 Billion | ₩52.88 Billion | ▼ -158.2% |
| 2013 | -0.09x | ₩-3.99 Billion | ₩45.68 Billion | ▼ -183.7% |
| 2012 | 0.10x | ₩5.02 Billion | ₩48.12 Billion | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.